Literature DB >> 17726851

Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.

Andrea Balch1, Andrew Mackin.   

Abstract

Immune-mediated hemolytic anemia (IMHA) is a common type of anemia in dogs and cats that results from a type II hypersensitivity reaction. The disease is most common in middle-aged female dogs, especially American cocker spaniels. The common clinical signs are associated with severe anemia and the resultant inflammatory response. There is no pathognomonic test for IMHA, but the following are suggestive of it: the presence of hemolytic anemia in a young adult or middle-aged dog of a predisposed breed, autoagglutination and/or spherocytosis, positive results from a direct antiglobulin (Coombs') test, elimination of any other underlying cause of anemia, and an appropriate response to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726851

Source DB:  PubMed          Journal:  Compend Contin Educ Vet        ISSN: 1940-8307


  10 in total

1.  A case of splenic torsion with progressive anemia and thrombocytopenia.

Authors:  Lisa M Schnier
Journal:  Can Vet J       Date:  2010-05       Impact factor: 1.008

2.  Pharmacodynamic assessment of ex-vivo canine T-lymphocyte proliferation: Responses to dexamethasone, cyclosporine, mycophenolic acid, and the active metabolite of leflunomide.

Authors:  Megan Grobman; Kaitlin A Bishop; Hansjorg Rindt; Laura A Nafe; Carol R Reinero
Journal:  Can J Vet Res       Date:  2019-10       Impact factor: 1.310

3.  Diagnostic utility of thoracic radiographs and abdominal ultrasound in canine immune-mediated hemolytic anemia.

Authors:  Michael Andres; Erik Hostnik; Eric Green; Catherine Langston; Valerie J Parker; Chen Gilor; Adam J Rudinsky
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

4.  Gingival overgrowth in a dog that received long-term cyclosporine for immune-mediated hemolytic anemia.

Authors:  Kazuhiko Namikawa; Takuya Maruo; Mayumi Honda; Hitomi Hirata; Jonathan Lynch; Hiroo Madarame
Journal:  Can Vet J       Date:  2012-01       Impact factor: 1.008

5.  Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.

Authors:  Christine J Piek; Willem Evert van Spil; Greet Junius; Aldo Dekker
Journal:  BMC Vet Res       Date:  2011-04-13       Impact factor: 2.741

Review 6.  Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia.

Authors:  J W Swann; B J Skelly
Journal:  J Vet Intern Med       Date:  2015-01-13       Impact factor: 3.333

Review 7.  Canine autoimmune hemolytic anemia: management challenges.

Authors:  James W Swann; Barbara J Skelly
Journal:  Vet Med (Auckl)       Date:  2016-07-26

8.  Complete Remission of Associative Immune-Mediated Hemolytic Anemia in a Dog Following Surgical Resection of Intestinal Leiomyosarcoma.

Authors:  Masashi Yuki; Eiji Naitoh
Journal:  Vet Sci       Date:  2019-06-13

9.  Erythrocyte sedimentation rate, C-reactive protein, and interleukin-6 as inflammatory biomarkers in dogs naturally infected with Ehrlichia canis.

Authors:  Thanaporn Asawapattanakul; Tanagorn Pintapagung; Supawadee Piratae; Siriluck Juntautsa; Pawarat Chancharoen
Journal:  Vet World       Date:  2021-09-04

10.  Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs.

Authors:  Jason P Bestwick; James Warland; Barbara J Skelly; James W Swann; Barbara Glanemann; Nick Bexfield; Zeta Gkoka; David J Walker; Paolo Silvestrini; Sophie Adamantos; Mayank Seth
Journal:  J Vet Intern Med       Date:  2022-07-07       Impact factor: 3.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.